Next Article in Journal
Exercise Counteracts the Deleterious Effects of Cancer Cachexia
Next Article in Special Issue
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
Previous Article in Journal
Development and Validation of the PaP Score Nomogram for Terminally Ill Cancer Patients
Previous Article in Special Issue
Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma—A Review
 
 
Article

Article Versions Notes

Cancers 2022, 14(10), 2511; https://doi.org/10.3390/cancers14102511
Action Date Notes Link
article pdf uploaded. 19 May 2022 17:14 CEST Version of Record https://www.mdpi.com/2072-6694/14/10/2511/pdf-vor
article supplementary file uploaded. 19 May 2022 17:14 CEST - https://www.mdpi.com/2072-6694/14/10/2511#supplementary
article supplementary file uploaded. 20 May 2022 08:12 CEST - https://www.mdpi.com/2072-6694/14/10/2511#supplementary
article xml file uploaded 21 May 2022 17:38 CEST Original file -
article xml uploaded. 21 May 2022 17:38 CEST Update https://www.mdpi.com/2072-6694/14/10/2511/xml
article pdf uploaded. 21 May 2022 17:38 CEST Updated version of record https://www.mdpi.com/2072-6694/14/10/2511/pdf
article html file updated 21 May 2022 17:39 CEST Original file -
article html file updated 3 August 2022 00:46 CEST Update https://www.mdpi.com/2072-6694/14/10/2511/html
Back to TopTop